Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jul-Aug;45(4):336-40.
doi: 10.1016/j.hrtlng.2016.03.007. Epub 2016 Apr 16.

Interleukin-12 serum level has prognostic value in patients with ST-segment elevation myocardial infarction

Affiliations

Interleukin-12 serum level has prognostic value in patients with ST-segment elevation myocardial infarction

Mikhail V Zykov et al. Heart Lung. 2016 Jul-Aug.

Abstract

Objectives: The study aimed to evaluate whether serum inflammatory markers have prognostic value in patients with ST-segment elevation myocardial infarction (STEMI).

Background: The role of cytokine-driven inflammation in the development of postdischarge complications after STEMI is obscured.

Methods: We recruited 214 patients who were admitted within 24 h of STEMI onset to our Institute. IL-1α, -6, -8, -10, -12, TNF-α, and CRP serum levels were measured on the 10-14th day after STEMI onset.

Results: Serum levels of IL-12, TNF-α, and CRP were significantly higher in patients with 3 affected coronary arteries compared to those with 1 affected coronary artery. However, only Killip class II-IV at admission and IL-12 serum level ≥90.0 pg/mL were defined as statistically significant predictors of adverse outcome after 1 year of follow-up.

Conclusion: IL-12 serum level may be suggested as a candidate prognostic marker if measured 10-14 days after STEMI onset.

Keywords: Atherosclerosis; Inflammation; Interleukin-12; Prognosis; ST-segment elevation myocardial infarction.

PubMed Disclaimer